Cyclin-dependent kinase inhibitor p27Kip1 expression in thyroid cells obtained by fine-needle aspiration biopsy: A preliminary report
- 5 July 2000
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 23 (2) , 77-81
- https://doi.org/10.1002/1097-0339(200008)23:2<77::aid-dc2>3.0.co;2-6
Abstract
Recent studies on paraffin‐embedded tissue have shown that the cyclin‐dependent kinase inhibitor p27Kip1 is expressed in normal thyroid cells, whereas it is downregulated in neoplastic cells. This prospective study was undertaken to assess whether p27Kip1 staining may also be applied to fine‐needle aspiration biopsy (FNAB) samples of the thyroid. We present here our preliminary results on 100 FNABs examined for p27Kip1 expression. p27Kip1 expression was assessed by immunocytochemistry; the technique was optimized on smears prepared from a normal thyreocyte cell line (TL5), which conspicuously expresses p27Kip1, and then applied to FNAB samples prospectively collected from 80 cases of nodular goiter and 20 cases of thyroid neoplasms (10 papillary carcinomas and 10 follicular neoplasms). The TL5 cell culture smears showed that methanol fixation, followed by heat‐induced antigen retrieval, is the most suitable technique for p27Kip1 staining on cytological samples. The FNAB smears similarly treated showed high p27Kip1 expression (75%) in goiter and a significantly lower expression (35%) in neoplasms (P < 0.0001). Our preliminary results show that: 1) p27Kip1 protein expression can be reliably assessed on cytological samples; and 2) p27Kip1 stains nonneoplastic and neoplastic samples in a different fashion, and thus is a useful tool in thyroid cytology. Diagn. Cytopathol. 23:77–81, 2000.Keywords
This publication has 13 references indexed in Scilit:
- Downregulation of p27KIP1 and Ki67/Mib1 Labeling Index Support the Classification of Thyroid Carcinoma Into Prognostically Relevant CategoriesThe American Journal of Surgical Pathology, 1999
- Transforming Growth Factor β Receptors and p27kip in Thyroid CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1999
- Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian TumorsThe American Journal of Pathology, 1999
- The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesisHuman Pathology, 1998
- Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma: Inverse Correlation with Disease-Free SurvivalThe American Journal of Pathology, 1998
- Cancer prognostics: Past, present and p27Nature Medicine, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994
- Fine needle aspiration cytology of medullary thyroid carcinoma: a review of 18 casesCytopathology, 1990
- Fine-Needle Aspiration Biopsy of the ThyroidAnnals of Internal Medicine, 1984